U.S. Markets closed

Celgene Corporation (CELG)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
136.44-1.40 (-1.02%)
At close: 4:00PM EDT

136.44 0.00 (0.00%)
After hours: 5:06PM EDT

People also watch
GILDBIIBREGNAMGNALXN
Full screen
Previous Close137.84
Open138.70
Bid136.44 x 100
Ask136.75 x 400
Day's Range135.86 - 138.90
52 Week Range96.93 - 138.93
Volume3,328,598
Avg. Volume3,983,336
Market Cap106.54B
Beta1.47
PE Ratio (TTM)51.24
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press43 minutes ago

    Celgene Corp. to pay $280M to settle cancer drug fraud suit

    LOS ANGELES (AP) — A New Jersey pharmaceutical company has agreed to pay $280 million to settle a federal lawsuit alleging it committed fraud promoting two cancer drugs for unapproved purposes.

  • Associated Press47 minutes ago

    Celgene Corp. to pay $280 million to settle lawsuit alleging it promoted cancer drugs for unapproved uses

    Celgene Corp. to pay $280 million to settle lawsuit alleging it promoted cancer drugs for unapproved uses.

  • Reuters56 minutes ago

    Celgene to pay $280 mln to settle off-label marketing case

    The U.S. Justice Department said on Tuesday that Celgene Corp had agreed to pay $280 million to settle a lawsuit that accused the company of promoting its cancer drugs Revlimid and Thalomid for off-label uses. In a statement, Celgene said it has agreed to resolve a "whistleblower" lawsuit that alleged it had violated the federal False Claims Act by submitting false claims to Medicare. The lawsuit alleged that Celgene violated the laws of 28 states and the District of Columbia by submitting fraudulent claims to state healthcare programs, including California's Medi-Cal program.